机构

• 上海药物研究所 [24]
• 高能物理研究所 [5]
• 深圳先进技术研究院 [4]
• 上海硅酸盐研究所 [3]
• 上海生物化学与细胞生... [2]
• 金属研究所 [1]
• 更多

采集方式

• OAI收割 [47]
• iSwitch采集 [2]

内容类型

• 期刊论文 [48]
• 学位论文 [1]

发表日期

• 2024 [1]
• 2023 [1]
• 2022 [5]
• 2021 [4]
• 2020 [5]
• 2019 [4]
• 更多

学科主题

• Cell Biolo... [2]
• Chemistry;... [2]
• Oncology [1]

筛选

浏览/检索结果: 共49条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 SIBP-03, a novel anti-HER3 antibody, exerts antitumor effects and synergizes with EGFR- and HER2-targeted drugs 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2024, 页码: 10 作者:  Li, Wen-jing;  Xie, Cheng-ying;  Zhu, Xi;  Tang, Jiao;  Wang, Lei   |  收藏  |  浏览/下载：4/0  |  提交时间：2024/02/19 SIBP-03  HER3  HER3-targeted therapy  neuregulin 1  EGFR  HER2   Vitamin B2-Based Ferroptosis Promoter for Sono-Enhanced Nanocatalytic Therapy of Triple-Negative Breast Cancer 期刊论文  OAI收割 ADVANCED FUNCTIONAL MATERIALS, 2023, 页码: 12 作者:  Zhou, Mengjiao;  Yuan, Minjian;  Jin, Yilan;  Zhou, Qianqian;  Yu, Yuting   |  收藏  |  浏览/下载：6/0  |  提交时间：2023/12/08 ferroptosis  nanocatalytic therapy  oxidative stress  redox homeostasis   Controlling Disassembly of Paramagnetic Prodrug and Photosensitizer Nanoassemblies for On-Demand Orthotopic Glioma Theranostics 期刊论文  OAI收割 ACS NANO, 2022, 卷号: 16, 期号: 12, 页码: 20607-20621 作者:  An, Ruibing;  Liu, Lingjun;  Wei, Shixuan;  Huang, Zheng;  Qiu, Ling   |  收藏  |  浏览/下载：13/0  |  提交时间：2023/04/10 coassembly  disassembly  imaging  synergistic therapy  glioma   Microvesicle-inspired oxygen-delivering nanosystem potentiates radiotherapy-mediated modulation of tumor stroma and antitumor immunity 期刊论文  OAI收割 BIOMATERIALS, 2022, 卷号: 290, 页码: 19 作者:  Gong, Xiang;  Li, Jie;  Xu, Xiaoxuan;  Wu, Yao;  Lei, Ying   |  收藏  |  浏览/下载：28/0  |  提交时间：2022/12/13 Microvesicle  Tumor hypoxia  Tumor stroma  Radiotherapy  Anti-tumor immune response   Circ_CEA promotes the interaction between the p53 and cyclin-dependent kinases 1 as a scaffold to inhibit the apoptosis of gastric cancer 期刊论文  OAI收割 CELL DEATH & DISEASE, 2022, 卷号: 13, 期号: 9, 页码: 15 作者:  Yuan, Yuan;  Zhang, Xiaojing;  Du, Kaining;  Zhu, Xiaohui;  Chang, Shanshan   |  收藏  |  浏览/下载：10/0  |  提交时间：2023/07/12 Lenvatinib- and vadimezan-loaded synthetic high-density lipoprotein for combinational immunochemotherapy of metastatic triple-negative breast cancer 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2022, 卷号: 12, 期号: 9, 页码: 3726-3738 作者:  Zheng, Chao;  Zhang, Wen;  Wang, Jinming;  Zhai, Yihui;  Xiong, Fengqin   |  收藏  |  浏览/下载：34/0  |  提交时间：2022/12/13 KEY WORDS High-density lipoprotein  Immunotherapy  Combination therapy  Metastasis  Triple-negative breast cancer  Lenvatinib  Vadimezan  Immune checkpoint blockade   Dual-responsive nanoparticles loading bevacizumab and gefitinib for molecular targeted therapy against non-small cell lung cancer 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2022, 页码: 11 作者:  Zhao, Zi-tong;  Wang, Jue;  Fang, Lei;  Qian, Xin-di;  Cai, Ying   |  收藏  |  浏览/下载：37/0  |  提交时间：2022/08/16 nanoparticles  molecular targeted therapy  non-small cell lung cancer  dual-responsive  controlled release   Endogenous Stimuli-Activatable Nanomedicine for Immune Theranostics for Cancer 期刊论文  OAI收割 ADVANCED FUNCTIONAL MATERIALS, 2021, 卷号: 31, 期号: 26, 页码: 30 作者:  Wang, Weiqi;  Jin, Yilan   |  收藏  |  浏览/下载：49/0  |  提交时间：2021/08/17 cancer immunotherapy  immune diagnosis  nanomedicine  stimuli-responsive  tumor microenvironment   P300/CBP inhibition sensitizes mantle cell lymphoma to PI3K delta inhibitor idelalisib 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2021, 页码: 13 作者:  Zhou, Xiao-ru;  Li, Xiao;  Liao, Li-ping;  Han, Jie;  Huang, Jing   |  收藏  |  浏览/下载：49/0  |  提交时间：2021/06/11 mantle cell lymphoma  idelalisib  drug resistance  P300  CBP  synergistic drug action  PI3Kδ  epigenetics   P300/CBP inhibition sensitizes mantle cell lymphoma to PI3K delta inhibitor idelalisib 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2021, 页码: 13 作者:  Zhou, Xiao-ru;  Li, Xiao;  Liao, Li-ping;  Han, Jie;  Huang, Jing   |  收藏  |  浏览/下载：54/0  |  提交时间：2021/06/11 mantle cell lymphoma  idelalisib  drug resistance  P300  CBP  synergistic drug action  PI3Kδ  epigenetics